| Review Article | ||||||||||||
RMJ. 2025; 50(3): 779-783 Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials Herwindo Ahmad, Refli Hasan, Naomi Niari Dalimunthe, Rahmad Isnanta, T. Realsyah, Zainal Safri.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Ahmad H, Hasan R, Dalimunthe NN, Isnanta R, Realsyah T, Safri Z. Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials. RMJ. 2025; 50(3): 779-783. doi:10.5455/rmj.20250324021049 Web Style Ahmad H, Hasan R, Dalimunthe NN, Isnanta R, Realsyah T, Safri Z. Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials. https://www.rmj.org.pk/?mno=249091 [Access: October 30, 2025]. doi:10.5455/rmj.20250324021049 AMA (American Medical Association) Style Ahmad H, Hasan R, Dalimunthe NN, Isnanta R, Realsyah T, Safri Z. Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials. RMJ. 2025; 50(3): 779-783. doi:10.5455/rmj.20250324021049 Vancouver/ICMJE Style Ahmad H, Hasan R, Dalimunthe NN, Isnanta R, Realsyah T, Safri Z. Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials. RMJ. (2025), [cited October 30, 2025]; 50(3): 779-783. doi:10.5455/rmj.20250324021049 Harvard Style Ahmad, H., Hasan, . R., Dalimunthe, . N. N., Isnanta, . R., Realsyah, . T. & Safri, . Z. (2025) Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials. RMJ, 50 (3), 779-783. doi:10.5455/rmj.20250324021049 Turabian Style Ahmad, Herwindo, Refli Hasan, Naomi Niari Dalimunthe, Rahmad Isnanta, T. Realsyah, and Zainal Safri. 2025. Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials. Rawal Medical Journal, 50 (3), 779-783. doi:10.5455/rmj.20250324021049 Chicago Style Ahmad, Herwindo, Refli Hasan, Naomi Niari Dalimunthe, Rahmad Isnanta, T. Realsyah, and Zainal Safri. "Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials." Rawal Medical Journal 50 (2025), 779-783. doi:10.5455/rmj.20250324021049 MLA (The Modern Language Association) Style Ahmad, Herwindo, Refli Hasan, Naomi Niari Dalimunthe, Rahmad Isnanta, T. Realsyah, and Zainal Safri. "Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials." Rawal Medical Journal 50.3 (2025), 779-783. Print. doi:10.5455/rmj.20250324021049 APA (American Psychological Association) Style Ahmad, H., Hasan, . R., Dalimunthe, . N. N., Isnanta, . R., Realsyah, . T. & Safri, . Z. (2025) Zilebesiran, a Small Interfering RNA agent as a potential novel antihypertensive treatment with cardiorenal protective effects: An overview of recent clinical trials. Rawal Medical Journal, 50 (3), 779-783. doi:10.5455/rmj.20250324021049 |
